Extracted from this filing and checked against the source text.
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Avalyn Pharma Inc.: Adopted amended and restated bylaws establishing stockholder meeting procedures, advance notice for proposals and director nominations, and conforming to charter amendments.
- Change
- bylaw amendment
Exact text from the filing
the amended and restated bylaws of the Company (the “Amended and Restated Bylaws”), previously approved by the Board and the Company’s stockholders to become effective immediately upon effectiveness of the Registration Statement, became effective.
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Avalyn Pharma Inc.: Filed amended and restated certificate of incorporation to authorize 700M shares of common stock (500M voting, 200M non-voting), eliminate references to prior preferred stock series, and authorize 10M shares of undesignated preferred stock.
- Change
- charter amendment
Exact text from the filing
the Company filed an amended and restated certificate of incorporation (the “Restated Certificate”) with the Secretary of State of the State of Delaware.
View on SEC.gov